Efficacy and tolerability of sofosbuvir and daclatasvir for treatment of hepatitis C genotype 1 & 3 in patients undergoing hemodialysis- a prospective interventional clinical trial

BACKGROUND: There is paucity of data using direct anti-viral agents (DAA) in patients on maintenance hemodialysis (MHD) infected with HCV-genotype 1 & 3. Aim of the study was to evaluate DAA therapy in patients infected with HCV-genotype 1 & 3 on MHD. METHODS: A prospective open label, paral...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheema, Shafiq Ur Rehman, Rehman, Muhammad Salman, Hussain, Ghulam, Cheema, Sidra Shafiq, Gilani, Nooman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883698/
https://www.ncbi.nlm.nih.gov/pubmed/31779583
http://dx.doi.org/10.1186/s12882-019-1631-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883698/
https://www.ncbi.nlm.nih.gov/pubmed/31779583
http://dx.doi.org/10.1186/s12882-019-1631-4

Ejemplares similares